These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 8721524

  • 21. Cytokine priming of human basophils: description of allergen 'nonreleasers'.
    Black KM, Lussier AM, Gion WR, Kasaian MT.
    Int Arch Allergy Immunol; 1996 Oct; 111(2):142-51. PubMed ID: 8859222
    [Abstract] [Full Text] [Related]

  • 22. Secretion of cytokines, histamine and leukotrienes in chronic urticaria.
    Ferrer M, Luquin E, Sanchez-Ibarrola A, Moreno C, Sanz ML, Kaplan AP.
    Int Arch Allergy Immunol; 2002 Nov; 129(3):254-60. PubMed ID: 12444324
    [Abstract] [Full Text] [Related]

  • 23. Studies on human basophil releasability.
    Marone G, Poto S, Giugliano R, Bonini S.
    Int Arch Allergy Appl Immunol; 1985 Nov; 77(1-2):103-6. PubMed ID: 2409008
    [Abstract] [Full Text] [Related]

  • 24. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    de Paulis A, Ciccarelli A, de Crescenzo G, Cirillo R, Patella V, Marone G.
    J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
    [Abstract] [Full Text] [Related]

  • 25. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria.
    Grattan CE, Francis DM, Hide M, Greaves MW.
    Clin Exp Allergy; 1991 Nov; 21(6):695-704. PubMed ID: 1723343
    [Abstract] [Full Text] [Related]

  • 26. Histamine release from gut mast cells from patients with inflammatory bowel diseases.
    Nolte H, Spjeldnaes N, Kruse A, Windelborg B.
    Gut; 1990 Jul; 31(7):791-4. PubMed ID: 1695160
    [Abstract] [Full Text] [Related]

  • 27. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.
    Kurimoto Y, De Weck AL, Dahinden CA.
    Eur J Immunol; 1991 Feb; 21(2):361-8. PubMed ID: 1705512
    [Abstract] [Full Text] [Related]

  • 28. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M, Horowitz EM, Botana LM, MacGlashan DW, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM.
    J Immunol; 1992 Jul 15; 149(2):599-608. PubMed ID: 1378071
    [Abstract] [Full Text] [Related]

  • 29. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
    Marone G, Cirillo R, Genovese A, Marino O, Quattrin S.
    Life Sci; 1989 Jul 15; 45(19):1745-54. PubMed ID: 2480501
    [Abstract] [Full Text] [Related]

  • 30. Histamine release from human basophils induced by platelet activating factor: the role of extracellular calcium, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Columbo M, Horowitz EM, Kagey-Sobotka A, Lichtenstein LM.
    J Allergy Clin Immunol; 1995 Feb 15; 95(2):565-73. PubMed ID: 7531728
    [Abstract] [Full Text] [Related]

  • 31. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.
    Niimi N, Francis DM, Kermani F, O'Donnell BF, Hide M, Kobza-Black A, Winkelmann RK, Greaves MW, Barr RM.
    J Invest Dermatol; 1996 May 15; 106(5):1001-6. PubMed ID: 8618029
    [Abstract] [Full Text] [Related]

  • 32. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
    Casolaro V, Spadaro G, Patella V, Marone G.
    J Immunol; 1993 Nov 15; 151(10):5563-73. PubMed ID: 7693814
    [Abstract] [Full Text] [Related]

  • 33. Cord blood basophil releasability: evaluation of histamine release and leukotriene C4 generation.
    Miadonna A, Leggieri E, Tedeschi A, Lorini M, Motta G, Lucci G, Froldi M, Marini A, Zanussi C.
    Int Arch Allergy Appl Immunol; 1988 Nov 15; 86(1):42-7. PubMed ID: 2453473
    [Abstract] [Full Text] [Related]

  • 34. Basophil mediator release in atopic dermatitis.
    Bull HA, Courtney PF, Bunker CB, Rustin MH, Pearce FL, Dowd PM.
    J Invest Dermatol; 1993 Mar 15; 100(3):305-9. PubMed ID: 7680056
    [Abstract] [Full Text] [Related]

  • 35. The mechanism of mediator release from human basophils induced by platelet-activating factor.
    Columbo M, Casolaro V, Warner JA, MacGlashan DW, Kagey-Sobotka A, Lichtenstein LM.
    J Immunol; 1990 Dec 01; 145(11):3855-61. PubMed ID: 1700998
    [Abstract] [Full Text] [Related]

  • 36. Impairment of the inhibitory effect of sodium on basophil histamine release in patients with systemic sclerosis.
    Tedeschi A, Palella M, Milazzo N, Mascagni B, Miadonna A.
    Clin Exp Immunol; 1996 Apr 01; 104(1):97-102. PubMed ID: 8603541
    [Abstract] [Full Text] [Related]

  • 37. Reduced priming effect of interleukin 3 on IgE mediated basophil histamine release in patients with systemic sclerosis.
    Tedeschi A, Salmaso C, Milazzo N, Miadonna A.
    J Rheumatol; 1998 Jul 01; 25(7):1320-4. PubMed ID: 9676763
    [Abstract] [Full Text] [Related]

  • 38. Differential effect of hypertonicity on FMLP-, anti-IgE- and Ca2+ ionophore A23187-induced histamine release from human basophil leukocytes.
    Tedeschi A, Arquati M, Lorini M, Miadonna A.
    Int Arch Allergy Appl Immunol; 1990 Jul 01; 93(4):359-64. PubMed ID: 1713571
    [Abstract] [Full Text] [Related]

  • 39. Autoimmunity and complement in the pathogenesis of chronic urticaria.
    Marsland AM.
    Curr Allergy Asthma Rep; 2006 Jul 01; 6(4):265-9. PubMed ID: 16822377
    [Abstract] [Full Text] [Related]

  • 40. The antineoplastic bryostatins affect human basophils and mast cells differently.
    Patella V, Casolaro V, Ciccarelli A, Pettit GR, Columbo M, Marone G.
    Blood; 1995 Mar 01; 85(5):1272-81. PubMed ID: 7532037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.